P/E Ratio

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

With results expected to beat guidance, all eyes are on Progyny's upcoming earnings as a key indicator for the rapidly expanding corporate family-building industry.

Align Partners launches a major governance overhaul campaign at Dentium, aiming to fix the 'Korea discount' and unlock value at the undervalued market leader.

Networking giant Belden reports record 2025 revenue and profit while launching a major strategic overhaul to dominate the converging IT and OT markets.

With its IPO complete, Cambridge Acquisition Corp. enters a disciplined SPAC market with a clear focus on wellness, hemp, and psychedelic tech targets.

With its lead drug in Phase 3, Celldex will update investors at three major conferences, highlighting its immunology pipeline and financial strategy.

With its stock soaring, AGF Management renews its buyback plan to repurchase 10% of its public float, a strategic move to boost value and manage dilution.

Sila Realty Trust sets its 2025 earnings date. Investors are watching to see if its strategic acquisitions and dividend policy signal strength for the sector.

In a surprise move, Sun Communities' new CFO is out after less than 30 days. His predecessor steps back in, aiming to calm markets amid a search.

Celebrating 100 years in the Caribbean, Holland America Line doubles down on its classic, relaxed cruise style, contrasting with today's mega-ship trend.

A cancer researcher's 2,115% gain and a Hong Kong trader's 1,499% two-year run redefine market outperformance in the 2025 Investing Championship.

The McDonald's franchisee giant plans up to 115 new Latin American stores, signaling strong confidence with a new focus on capital efficiency.

Babcock & Wilcox appoints Dr. Homaira Akbari, a tech and AI expert, signaling a major strategic push into powering the booming data center industry.

A new industry report reveals how AI, electrification, and procurement shifts are forcing a major reckoning in electronics. Here’s what it means for the future.

A worker's death at Serabi Gold's Coringa mine puts the company's ambitious growth plans and safety record under intense scrutiny in Brazil.

Flexible Solutions posts modest 2025 revenue gains, but a major strategic shift to food-grade products and new factories sets the stage for a breakout year.

As NETSCOUT prepares its Q3 FY26 report, all eyes are on whether it can meet high expectations and signal the health of enterprise security spending.

Toro Corp. paid a massive special dividend, exciting investors. We dig into the cash-vs-stock option, market reaction, and what it means for the firm's future.

The genomics leader posted a 41% revenue surge in 2025 and projects profitability, yet its stock tumbled on what some see as conservative 2026 guidance.

ChipMOS reports stunning 20.8% Q4 growth, highlighting a memory chip frenzy fueled by AI and datacenters. Is this the start of a new tech supercycle?